Milestone Pharmaceuticals Inc. logo

Milestone Pharmaceuticals Inc.

NASDAQ:MIST

Overview | Financials
Company Name Milestone Pharmaceuticals Inc.
Symbol MIST
Currency USD
Price 2.17
Market Cap 115,721,543
Dividend Yield 0%
52-week-range 1.12 - 2.75
Industry Biotechnology
Sector Healthcare
CEO Mr. Joseph G. Oliveto M.B.A.
Website https://www.milestonepharma.com

An error occurred while fetching data.

About Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II clinical trial for

Related Stocks

CymaBay Therapeutics, Inc. logo

CymaBay Therapeutics, Inc.

CBAY

32.48 USD

Co-Diagnostics, Inc. logo

Co-Diagnostics, Inc.

CODX

0.484 USD

Mainz Biomed B.V. logo

Mainz Biomed B.V.

MYNZ

4.365 USD

Aldeyra Therapeutics, Inc. logo

Aldeyra Therapeutics, Inc.

ALDX

6.91 USD

Omeros Corporation logo

Omeros Corporation

OMER

8.42 USD

Rhythm Pharmaceuticals, Inc. logo

Rhythm Pharmaceuticals, Inc.

RYTM

50.97 USD

Beyond Air, Inc. logo

Beyond Air, Inc.

XAIR

0.269 USD

Fusion Pharmaceuticals Inc. logo

Fusion Pharmaceuticals Inc.

FUSN

21.55 USD

Financials

Numbers are in millions USD

Numbers are in millions USD